Structure–activity studies of Ti(IV) complexes: aqueous stability and cytotoxic properties in colon cancer HT-29 cells

As part of our research efforts in the area of titanium-based antitumor agents, we have investigated the cytotoxic activity of [Ti(4)(maltolato)(8)(mu-O)(4)], (Cp-R)(2)TiCl(2) and (Cp-R)CpTiCl(2) (R = CO(2)CH(3) and CO(2)CH(2)CH(3)), and three water-soluble titanocene-amino acid complexes-[Cp(2)Ti(aa)(2)]Cl(2) (aa = L: -cysteine, L: -methionine, and D: -penicillamine)-on the human colon adenocarcinoma cell line, HT-29. The capacity of [Ti(4)(maltolato)(8)(mu-O)(4)] to donate Ti(IV) to human apo-transferrin and its hydrolytic stability have been investigated and compared to the previously reported data on modified titanocenes with either hydrophilic ancillary ligands or the functionalized cyclopentadienyl ligands. Notably, the titanium-maltolato complex does not transfer Ti(VI) to human apo-transferrin at any time within the first seven days of its interaction, demonstrating the inert character of this species. Stability studies on these complexes have shown that titanocene complexes decompose at physiological pH while the [Ti(4)(maltolato)(8)(mu-O)(4)] complex is stable at this pH without any notable decomposition for a period of ten days. The antitumor activity of these complexes against colon cancer HT-29 cells was determined using an MTT cell viability assay at 72 and 96 h. The titanocene-amino acid and the (Cp-R)(2)TiCl(2)/(Cp-R)CpTiCl(2) (R = CO(2)CH(3)) complexes were not biologically active when human transferrin was absent; they also were inactive when human transferrin was present at dose-equivalent concentrations. (Cp-R)(2)TiCl(2) and (Cp-R)CpTiCl(2) (R = CO(2)CH(2)CH(3)) showed cytotoxic activity in HT-29 cells comparable to that which is displayed by titanocene dichloride. The titanium-maltolato complex had higher levels of cytotoxic activity than any other titanocene complex investigated. Transferrin may be important in protecting the titanium center from hydrolysis, but this may be achieved by selecting ligands that could result in hydrolytically stable, yet active, complexes.     

Interactions of dichloro-bis(η5-cyclopentadienyl)titanium(IV) with nucleosides

The interactions of dichloro-bis(η⁵-cyclopentadienyl)titanium(IV) (titanocene dichloride, Cp₂TiCl₂) with nucleosides have been studied in methanolic solutions. Complexes of the general formula [Cp₂Ti(Nucl)MeOH]Cl₂ were isolated. The nucleoside complexes with one N(1)H ionizable imino proton (i.e. inosine and guanosine) undergo ionization in alkaline solution and complexes of the formula [Cp₂Ti(NuclH⁺)] Cl were isolated. All complexes have been characterized by elemental analyses and various spectroscopic techniques. In the first series of complexes, [Cp₂Ti(Nucl)MeOH]Cl₂, the nucleosides act as monodentate ligands with an intramolecular hydrogen bond between the coordinated methanol and the C6O group, while in the second, [Cp₂Ti(NuclH⁺)] Cl, they coordinate through both their N7 and O6 atoms.     

Antitumor properties of some titanocene chalcogenates

Five chalcogen-coordinated bis(η⁵-cyclopentadienyl)titanium(IV) chalcogenolates were tested against fluid Ehrlich ascites tumor for antitumor properties: the titanocene phenolates (C₅H₅)₂TiCl(2,4,6-OC₆H₂Cl₃) (I) and (C₅H₅)₂Ti(OC₆F₅)₂ (II); the titanocene thiophenolate (C₅H₅)₂Ti(SC₆F₅)₂ (III); the titanocene dithiolene chelate (C₅H₅)₂Ti[cis-1,2-S₂C₂ (CN)₂] (IV); and the titanocene selenophenolate (C₅H₅)₂TiCl(SeC₆H₅) (V). The best antitumor activity and an optimum cure rate of 100% were observed in the case of the pentafluorophenyl derivatives II and III, followed by IV and V which induced cure rates of 90 and 80% respectively. These results confirm that bis(η⁵-cyclopentadienyl)titanium(IV) diacido complexes can be widely varied at the position of the acido ligands without loss of antitumor potency. The titanocene derivatives described in the present study are the first neutral mercapto and seleno titanocene derivatives for which strong antiproliferative properties have been shown.     

Antitumor activity of titanocene amino acid complexes

Seven ionic titanocene -amino acid (aa) complexes [(C₅H₅)₂Ti(aa)₂]²⁺[X]₂ ^– with aa = glycine,l-alanine, 2-methylalanine,d-l-phenylalanine,d,l-4-fluorophenylalanine and X = Cl or AsF₆, were investigated for antitumor activity against fluid Ehrlich ascites tumor growing in CF1 mice. These complexes are the first stable model compounds of titanocene units with protein components, synthesized from a water-like, methanolic medium. All titanocene amino acid complexes induced antitumor activity which was manifested by maximum cure rates ranging from 30 to 70% and increases in life span from 78 to 276% in comparison with untreated control animals. The complexes containing chloride as anion X were more effective than the hexafluoroarsenate derivatives, which surprisingly showed a low substance toxicity. In all cases, the antitumor activity of the ionic titanocene amino acid complexes tested was less pronounced than that of the neutral parent compound [(C₅H₅)₂TiCl₂].     

Ethanol catalyzed synthesis of titanocene aryl carboxylate complexes and crystal structure of (η-C5H5)2Ti(2-OH-5-S-O2CC6H3)2

A method for the synthesis of titanocene (IV) aryl carboxylate complexes is presented in this paper. It is based on the fact that alcohol can catalyze the reaction between Cp₂TiCl₂ and aryl carboxylate ligands in the presence of sodium hydroxide (NaOH). The effects of the catalyst on the reaction system were studied and the possible reaction mechanism was proposed. This method was used to prepare a series of titanocene (IV) aryl carboxylate complexes and a macrocyclic titanocene (5,5′-dithiodisalicylato titanocene), whose structure was determined by X-ray diffraction analysis.     

Formation of titanium(IV) transferrin by reaction of human serum apotransferrin with titanium complexes

The reaction of human serum apotransferrin with titanium(IV) citrate under physiological conditions results in the formation of a specific bis-titanium(IV) transferrin adduct (Ti₂Tf hereafter) with two titanium(IV) ions loaded at the iron binding sites. The same specific Ti₂Tf complex is formed by reacting apotransferrin with titanium(III) chloride and exposing the sample to air. The derivative thus obtained was characterized by spectroscopic techniques, including absorption, UV difference, circular dichroism and ¹³C NMR spectroscopies, and shown to be stable within the pH range 5.5–9.0. Surprisingly, the reaction of apoTf with titanium(IV) nitrilotriacetate (NTA) does not lead to formation of appreciable amounts of Ti₂Tf, even after long incubation times, although some weak interactions of Ti(IV)NTA with apoTf are spectroscopically detected. Implications of the present results for a role of transferrin in the uptake, transport and delivery of soluble titanium(IV) compounds under physiological conditions are discussed.     

Binding and hydrolysis studies of antitumoural titanocene dichloride and Titanocene Y with phosphate diesters

The interaction of the antitumoural metallocene dihalides, titanocene dichloride (Cp₂TiCl₂) and Titanocene Y (bis-[(p-methoxybenzyl)cyclopentadienyl]titanium(IV) chloride), with bis(4-nitrophenyl) phosphate (BNPP), which is a widely used model for the phosphate diester linkages in DNA, has been studied. Cp₂TiCl₂ has been shown to promote the cleavage of the phosphate diester in weakly acidic solution. At pH 4, 37 °C, a 10⁶-fold rate acceleration over the uncatalysed reaction was observed under pseudo-first-order conditions, when freshly prepared solutions of Cp₂TiCl₂ were applied. The activity of aged solutions dropped significantly due to the formation of insoluble precipitates of hydrolysed Ti species. The precipitates isolated from aged solutions were shown to act as moderately active, heterogeneous catalysts for BNPP cleavage. By contrast, no hydrolysis of the phosphate diester could be observed in the presence of Titanocene Y. Implications for the mode of action of the apoptosis-inducing metallocene dihalides are discussed.     

Isomer distribution and structure of (2,2′-biphenyldiolato)bis(β-diketonato)titanium(IV) complexes: A single crystal X-ray, solution NMR and computational study

Novel dichlorobis(β-diketonato)titanium(IV) Ti(C₆H₅COCHCOR)₂Cl₂ and (2,2′-biphenyldiolato)bis(β-diketonato)titanium(IV) Ti(C₆H₅COCHCOR)₂biphen complexes with R = CH₃, C₆H₅ and CF₃, are synthesized and characterized by X-ray crystallography and further physical methods. There is a good agreement between DFT calculated and experimental structural data. A configurational analysis gives a calculated isomer distribution that is in agreement with the experimental data derived from low temperature ¹H NMR spectroscopy. The Ti(C₆H₅COCHCOR)₂biphen complexes exhibit high hydrolytic stability.     

Some new derivatives of organozirconium(IV) and organotitanium(IV) with thiophenecarboxylic acids

The complexes of the type Cp₂M(3-TC)Cl, Cp₂M(3-TC)₂, Cp₂M(3-TA)Cl, Cp₂M(3-TA)₂, Cp₂M(2-TB)Cl, Cp₂M(2-TB)₂ [where Cp = cyclopentadienyl, M = Zr or Ti] were synthesized by the reactions of dichlorobis(cyclopentadienyl)zirconium(IV) and dichlorobis(cyclopentadienyl)titanium(IV) with 3-thiophenecarboxylic acid (3-TCH), 3-thiopheneacetic acid (3-TAH) and 2-thiophenebutyric acid (2-TBH) respectively in different stoichiometric ratios. The new complexes were characterized by their elemental analysis, ¹H NMR, IR, and electronic spectral data.     

Synthesis and characterization of transition metal complexes bearing tetrafluoro-4-pyridyl substituent on the cyclopentadienyl ring

The reaction of sodium cyclopentadienide (NaCp) with pentafluoropyridine gives Na[4-(C₅F₄N)C₅H₄] (^PyFCpNa, 1) contaminated with starting NaCp from which pure 1 could be extracted with Et₂O. Hydrolysis of 1 and subsequent crystallization gives pure Diels-Alder dimer 1,4-bis(tetrafluoro-4-pyridyl)tricyclo[5.2.1.0^2,6]deca-3,8-diene (2). The reactions of 1 with FeCl₂, [MnBr(CO)₅], CoBr₂, [Ni(NH₃)₆]Cl₂, [TiCl₄(THF)₂] and [CpTiCl₃] cleanly affords the corresponding metallocenes [Fe(^PyFCp)₂] (3), [(^PyFCp)Mn(CO)₃] (5), [Co(^PyFCp)₂] (6), [Ni(^PyFCp)₂] (8), [(^PyFCp)₂TiCl₂] (9) and [(^PyFCp)(Cp)TiCl₂] (10), respectively. Tetrafluoro-4-pyridyl-substituted ferrocene 3 and [Fe(^PyFCp)(Cp)] (4) can be alternatively prepared by the reaction of the respective lithioferrocenes with C₅F₅N in THF. Air-oxidation of complex 6 affords the corresponding cobaltocenium salt [Co(^PyFCp)₂]PF₆ (7). All prepared compounds were characterized spectroscopically and by elemental analysis. The crystal structures of 3-7 were determined, revealing extensive arene π?π stacking and C-H?F-C contacts. Electrochemical studies supported with the spectroscopic data of the prepared metallocene complexes evidenced strong electron-withdrawing nature of the tetrafluoro-4-pyridyl substituent.     

Titanium(IV) targets phosphoesters on nucleotides: implications for the mechanism of action of the anticancer drug titanocene dichloride

Abstract Reactions between the anticancer drug titanocene dichloride (Cp2TiCl2) and various nucleotides and their constituents in aqueous solution or N,N-dimethylformamide (DMF) have been investigated by 1H and 31P NMR spectroscopy and in the solid state by IR spectroscopy. In aqueous solution over the pH* (pH meter reading in D2O) range 2.3-6.5, CMP forms one new species with Ti(IV) bound only to the phosphate group. In acidic media at pH*<4.6, three species containing titanocene bound to the phosphate group of dGMP, AMP, dTMP and UMP are formed rapidly. The bases also appear to influence titanocene binding. Only one of these Ti(IV)-bound species can be detected in the pH* range of 4.6-6.5 in each case. The order of reactivity towards Cp2TiCl2(aq) at pH* ca. 3 is GMP>TMP approximately AMP > CMP. At pH* > 7.0, hydrolysis of Cp2TiCl2 predominated and little reaction with the nucleotides was observed. Binding of deoxyribose 5'-phosphate and 4-nitrophenyl phosphate to Cp2TiCl2(aq) via their phosphate groups was detected by 31P NMR spectroscopy, but no reaction between Cp2TiCl2(aq) and deoxyguanosine, 9-ethylguanine or deoxy-D-ribose was observed in aqueous solution. The nucleoside phosphodiesters 3',5'-cyclic GMP and 2',3'-cyclic CMP did not react with Cp2TiCl2(aq) in aqueous solution; however, in the less polar solvent DMF, 3',5'-cyclic GMP coordination to [Cp2Ti]2+ via its phosphodiester group was readily observed. Binding of titanocene to the phosphodiester group of the dinucleotide GpC was also observed in DMF by 31P NMR. The nucleoside triphosphates ATP and GTP reacted more extensively with Cp2TiCl2(aq) than their monophosphates; complexes with bound phosphate groups were formed in acidic media and to a lesser extent at neutral pH. Cleavage of phosphate bonds in ATP (and GTP) by Cp2TiCl2(aq) to form inorganic phosphate, AMP (or GMP) and ADP (or GDP) was observed in aqueous solutions. In addition, titanocene binding to ATP was not inhibited by Mg(II), but the ternary complex titanocene-ATP-Mg appeared to form. These reactions contrast markedly with those of the drug cisplatin, which binds predominantly to the base nitrogen atoms of nucleotides and only weakly to the phosphate groups. The high affinity of Ti(IV) for phosphate groups may be important for its biological activity.     

Electron transfer. Part 165: Oxidations of Ti(II)(aq) with ligated iron(III) and ruthenium(III)

Titanium(II) solutions, prepared by dissolving titanium wire in triflic acid + HF, contain equimolar quantities of Ti(IV). Treatment of such solutions with excess Fe(III) or Ru(III) complexes yield Ti(IV), but reactions with Ti(II) in excess give Ti(III). Oxidations by (NH₃)₅Ru(III) complexes, but not by Fe(III) species, are catalyzed by titanium(IV) and by fluoride. Stoichiometry is unchanged. The observed rate law for the Ru(III)-Ti(II)-Ti(IV) reactions in fluoride media points to competing reaction paths differing by a single F⁻, with both routes involving a Ti(II)-Ti(IV) complex which is activated by deprotonation. It is suggested that coordination of Ti(IV) to Ti^II(aq) minimizes the mismatch of Jahn-Teller distortions which would be expected to lower the Ti(II,III) self-exchange rate.     

Novel derivatives of ansa-titanocenes procured from 6-phenylfulvene: a combined experimental and theoretical study

The previously prepared trans-[(1,2-diphenyl-1,2-dicyclopentadienyl)ethanediyl] titanium(IV) dichloride, [1,2-(Ph)₂C₂H₂{η⁵-C₅H₄}₂]Ti(Cl)₂, was synthesised using an alternative procedure, from which its crystal structure was determined. Using this compound, a variety of other ansa-titanocene derivatives were synthesised by replacement of the chloride ligands with selected substituents. Thus RTi(X)(Y) systems where R=1,2-(Ph)₂C₂H₂η⁵-C₅H₄₂; X=Y=CH₃; X=CH₃, Y=Cl; X=Y=NCS; X=Y=NCO; X=Y=OPh and (X/Y)=O have been synthesised and characterised. DFT calculations were performed on the complexes trans-[(1,2-diphenyl-1,2-dicyclopentadienyl)-ethanediyl] titanium(IV) dichloride, bis-(6,6-diphenylfulvene)titanium and bis-(6,6-diphenylfulvene)iron. This demonstrated the role that the metal centre plays in their formation, generating either an ansa-metallocene, a ‘tucked in’ fulvene complex or a metallocene coordinating fulvene anions.     

Cytotoxic studies of substituted titanocene and ansa-titanocene anticancer drugs

A variety of substituted titanocene and ansa-titanocene complexes have been synthesized and characterized using traditional methods. The cytotoxic activity of the different titanocene complexes was tested against tumour cell lines human adenocarcinoma HeLa, human myelogenous leukemia K562, human malignant melanoma Fem-x and normal immunocompetent cells, peripheral blood mononuclear cells PBMC. Alkenyl substitution, either on the cyclopentadienyl ring or on the silicon-atom ansa-bridge of the titanocene compounds [Ti{Me₂Si(η⁵-C₅Me₄)(η⁵-C₅H₃{CMe₂CH₂CH₂CHCH₂})}Cl₂] (8), [Ti{Me(CH₂CH)Si(η⁵-C₅Me₄)(η⁵-C₅H₄)}Cl₂] (9) and [Ti(η⁵-C₅H₄{CMe₂CH₂CH₂CHCH₂})₂Cl₂] (12) showed higher cytotoxic activities (IC₅₀ values from 24 ± 3 to 151 ± 10 μM) relative to complexes bearing an additional alkenyl-substituted silyl substituent on the silicon bridge [Ti{Me{(CH₂CH)Me₂SiCH₂CH₂}Si(η⁵-C₅Me₄)(η⁵-C₅H₄)}Cl₂] (10) and [Ti{Me{(CH₂CH)₃SiCH₂CH₂}Si(η⁵-C₅Me₄)(η⁵-C₅H₄)}Cl₂] (11) which causes a dramatic decrease of the cytotoxicity (IC₅₀ values from 155 ± 9 to >200 μM). In addition, the synthesis of the analogous niobocene complex [Nb(η⁵-C₅H₄{CMe₂CH₂CH₂CH=CH₂})₂Cl₂] (13), is described. Structural studies based on DFT calculations of the most active complexes 8, 9 and 12 and the X-ray crystal structure of 13 are reported.     

Ti(IV) uptake and release by human serum transferrin and recognition of Ti(IV)-transferrin by cancer cells: understanding the mechanism of action of the anticancer drug titanocene dichloride

The organometallic anticancer agent titanocene dichloride, Cp(2)TiCl(2), is now in phase II clinical trials as an anticancer drug, but its mechanism of action is poorly understood. We show here that the interactions of Cp(2)TiCl(2) with human serum transferrin (hTF) and that of Ti(2)-hTF with adenosine triphosphate (ATP) have characteristics that could allow transferrin to act as a mediator for titanium delivery to tumor cells. Such reactions may therefore be important to the anticancer activity of this new class of drugs. Cp(2)TiCl(2) reacts rapidly with human apo-transferrin under physiological conditions (100 mM NaCl, 25 mM bicarbonate, and 4 mM phosphate, pH 7.4) with carbonate as a synergistic anion. The Cp ligands are released from the drug. Two-dimensional [(1)H, (13)C] NMR studies of epsilon-[(13)C]Met-hTF show that Ti(IV) loads the C-lobe first followed by the N-lobe and binds in the specific Fe(III) sites. The protein conformational changes induced by Ti(IV) appear to be similar to those induced by Fe(III). Carbonate can act as a synergistic anion in Ti(2)-hTF but does not appear to be essential. A specific Ti(IV)-hTF adduct is formed even in the absence of bicarbonate. When the pH of Ti(2)-hTF solutions is lowered, no Ti(IV) is released at the endosomal pH of ca. 5.0-5.5, but one Ti(IV) dissociates between pH 4.5-2.0. In contrast, in the presence of 1 mM ATP, all Ti(IV) is readily released from both lobes when the pH is lowered from 7.0 to 4.5. Moreover, Fe(III) displaces Ti(IV) rapidly from the C-lobe of Ti(2)-hTF (<5 min) but only slowly (days) from the N-lobe. Thus, the species Fe(C)Ti(N)-hTF might also provide a route for Ti(IV) entry into tumor cells via the transferrin receptor. Ti(2)-hTF effectively blocked cell uptake of radiolabeled (59)Fe-hTF into BeWo cells, a human placental choriocarcinoma cell line in culture. These results imply that titanium transferrin might be recognized by the transferrin receptor and be taken up into cancer cells.     

Intracellular mapping of the distribution of metals derived from the antitumor metallocenes

The intracellular distribution of transition metals in V79 Chinese hamster lung cells treated with subtoxic doses of the organometallic anticancer complexes Cp₂MCl₂, where Cp is η ⁵ -cyclopentadienyl and M is Mo, Nb, Ti, or V, has been studied by synchrotron-based X-ray fluorescence (XRF). While significantly higher concentrations of Mo and Nb were found in treated cells compared with control cells, distinct differences in the cellular distribution of each metal were observed. Analysis of thin sections of cells was consistent with some localization of Mo in the nucleus. Studies with a noncytotoxic thiol derivative of molybdocene dichloride showed an uneven distribution of Mo in the cells. For comparison, the low levels of Ti and V in cells treated with the more toxic titanocene and vanadocene complexes, respectively, resulted in metal concentrations at the detection limit of XRF. The results agree with independent chemical studies that have concluded that the biological chemistry of each of the metallocene dihalides is unique.Electronic Supplementary Material Supplementary material is available for this article at .     

Monohalogenobenzoylhydrazones II. Synthesis and Study of Ti(IV) Complexes with Monochlorobenzoylhydrazones of 2-Furaldehyde, 2-Thiophenaldehyde, 2-Pyrrolaldehyde and Di-2-pyridylketone as Ligands

Sixteen new titanium(IV) complexes of the general formulae L₂TiCl₂ [L⁻ = benzoyl and mono- chlorobenzoylhydrazones of 2-furaldehyde(FBH-H and FC1BH-H), 2-thiophenaldehyde(TBH-H and TC1- BH-H), 2-pyrrolaldehyde(PBH-H and PC1BH-H)] and L′TiCl3 [L′ = benzoyl and monochlorobenzoyl- hydrazones of di-2-pyridylketone (DBH-H and DC1BH-H)] have been prepared and characterised by various physicochemical methods. All ligands appear to be coordinated to the titanium through the carbonyl and azomethine groups in a bidentate fashion, with the exception of the DBH and DC1BH molecules, which act as tridentate ligands involving the nitrogen atom of the pyridyl group in their coordination.     

Titanium complexes with chiral amino alcohol ligands: synthesis and structure of complexes related to hydroamination catalysts

Titanium complexes with chiral amino alcohol ligands are useful precatalysts for the intramolecular hydroamination of aminoallenes. They can be synthesized via protonolysis of titanium dimethylamide starting materials with the free ligand. In most cases, the resulting materials are not isolable due to their oily nature. However, several complexes were prepared in pure form and isolated as solid materials. [Ti(Cl)(NMe₂)(-OCH₂CH(Ph)N(CHMe₂)-]₂ was prepared at room temperature from TiCl(NMe₂)₃ and the corresponding N-substituted d-amino alcohol; the dimeric nature of the complex was established by X-ray crystallography. [Ti(NMe₂)₂(-OCH₂CH(Ph)N(2-Ad)-)]₂ (2-Ad = 2-Adamantyl) was prepared from Ti(NMe₂)₄ and the corresponding N-substituted l-amino alcohol after prolonged heating. An intermediate complex that could not be purified or isolated is believed to be Ti(NMe₂)₃(-OCH₂CH(Ph)NH(2-Ad)). Two complexes with the composition TiCl₂(-OCH₂CH(R*)N(CHMe₂)-)(HNMe₂) (where R* = CH₂Ph or CHMe₂) were prepared at room temperature by protonolysis of TiCl₂(NMe₂)₂ with the corresponding N-substituted l-amino alcohols. These two complexes exhibit dynamic behavior on the NMR timescale that is believed to be a dimer-monomer equilibrium, but they decompose at elevated temperatures.     

Synthesis,Spectral and Antibacterial Studies of Binuclear Titanium(IV) / Zirconium(IV) Complexes of Piperazine Dithiosemicarbazones

The reactions of mono(cyclopentadienyl)titanium(IV) trichloride and bis(cyclopentadienyl)titanium(IV)/ zirconium(IV) dichloride with a new class of dithiosemicarbazone, derived by condensing piperazine dithiosemicarbazide with benzaldehyde (L₁H₂), 2-chlorobenzaldehyde (L₂H₂), 4-nitrobenzaldehyde (L₃H₂) or salicylaldehyde (L₄H₄) have been studied and different types of binuclear products, viz. [{CpTiCl₂}₂L], [{Cp₂MCl}₂L], ((L=L₁, L₂ or L₃), [{CpTiCI}₂L₄] and [{Cp₂M}₂L₄] (M=Yi or Zr), have been isolated. Tentative structures are proposed for these complexes based upon elemental analyses, electrical conductance, magnetic moment and spectral (electronic, IR, ¹H and ¹³C NMR) data. Attempts have been made to establish a correlation between antibacterial activity and the structures of the products.     

Synthesis and structure of titanium alkoxides based on tetraphenyl substituted 2,6-dimethanolpyridine moiety

Novel titanocanes and spirobititanocanes based on 2,6-bis[hydroxy(diphenyl)methyl]pyridine (1a) and 2,6-di(hydroxymethyl)pyridine (1b) - [2,6-C₅H₃N(CPh₂O)₂]Ti(O-i-Pr)₂ (2a), [2,6-C₅H₃N(CPh₂O)₂]₂Ti (3a), [2,6-C₅H₃N(CH₂O)₂]₂Ti (3b), [2,6-C₅H₃N(CPh₂O)₂]TiCl₂ (4) - as well as the closely related N-phenyl derivative PhN(CH₂CH₂O)₂Ti(Cl)Cp (5) have been synthesized. Complexes 2-5 were characterized by ¹H and ¹³C NMR spectroscopy and elemental analysis data. The molecular structure of 3a was determined by X-ray structure analysis.